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Abstract
©  2016  The  Author(s).Acrolein,  a  highly  toxic  α,  β-unsaturated  aldehyde,  has  been  a
longstanding key biomarker associated with a range of disorders related to oxidative stresses.
One of the most promising methods for detecting acrolein involves the use of antibodies that
can  recognize  the  acrolein-lysine  conjugate,  3-formyl-3,  4-dehydropiperidines  (FDP),  within
oxidatively stressed cells and tissues from various disease states. We have uncovered here that
FDP could reduce nitroarenes in high yields at 100 °C in the presence of excess CaCl 2 as a
Lewis acid promoter. This unique transformation allowed for the development of a de novo
method for detecting levels of FDPs generated from proteins in urine or blood serum samples.
Thus we successfully converted a non-fluorescent and inexpensive 4-nitrophthalonitrile probe to
the corresponding fluorescent aniline, thereby constituting the concept of fluorescent switching.
Its sensitivity level (0.84 nmol/mL) is more than that of ELISA assays (3.13 nmol/mL) and is
already equally reliable and reproducible at this early stage of development. More importantly,
this method is cost effective and simple to operate, requiring only mixing of samples with a kit
solution. Our method thus possesses potential as a future alternative to the more costly and
operatively encumbered conventional antibody-based methods.
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